AKT Inhibitors pipeline
Mar 24, 2017
AKT Inhibitors: A potential Cancer Immunotherapy Target
Targeted therapy is the most preferred option for cancer treatment and a number of new targets are being discovered which target cancer specific receptors, AKT being one of them. Protein kinase B (PKB), also known as AKT, belongs to serine/threonine protein kinase superfamily. AKT has been validated as a potential t...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
